KODIAK SCIENCES INC. Investment Income, Interest
KODIAK SCIENCES INC. (KOD) reported Investment Income, Interest of $1.25 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-13
- KODIAK SCIENCES INC. investment income, interest for the quarter ending 2026-06-30 was $1.25M, a 1.13% increase year-over-year.
- KODIAK SCIENCES INC. investment income, interest for the quarter ending 2026-03-31 was $1.64M, a 2.43% increase year-over-year.
- KODIAK SCIENCES INC. investment income, interest for the quarter ending 2025-12-31 was $757.00K, a 64.46% decline year-over-year.
- KODIAK SCIENCES INC. investment income, interest for the quarter ending 2025-09-30 was $917.00K, a 66.17% decline year-over-year.
- KODIAK SCIENCES INC. investment income, interest for fiscal 2025 was $4.52M, a 59.48% decline from fiscal 2024.
- KODIAK SCIENCES INC. investment income, interest for fiscal 2024 was $11.15M, a 33.38% decline from fiscal 2023.
- KODIAK SCIENCES INC. investment income, interest for fiscal 2023 was $16.73M, a 136.64% increase from fiscal 2022.
- KODIAK SCIENCES INC. investment income, interest for fiscal 2022 was $7.07M, a 2272.82% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 6 month as first filed | Investment Income, Interest 9 month | Investment Income, Interest 9 month as first filed | Investment Income, Interest 12 month | Investment Income, Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.25M 10-Q · filed 2026-08-13 | $2.90M 10-Q · filed 2026-08-13 | $3.65M derived: sum of 3 quarters · filed 2026-08-13 | $4.57M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $1.64M 10-Q · filed 2026-05-07 | $2.40M derived: sum of 2 quarters · filed 2026-05-07 | $3.31M derived: sum of 3 quarters · filed 2026-05-07 | $4.56M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $757.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.67M derived: sum of 2 quarters · filed 2026-03-31 | $2.92M derived: sum of 3 quarters · filed 2026-08-13 | $4.52M 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $917.00K 10-Q · filed 2025-11-13 | $2.16M derived: sum of 2 quarters · filed 2026-08-13 | $3.76M 10-Q · filed 2025-11-13 | $5.89M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $1.24M 10-Q · filed 2026-08-13 | $2.84M 10-Q · filed 2026-08-13 | $4.97M derived: sum of 3 quarters · filed 2026-08-13 | $7.68M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $1.60M 10-Q · filed 2026-05-07 | $3.73M derived: sum of 2 quarters · filed 2026-05-07 | $6.44M derived: sum of 3 quarters · filed 2026-05-07 | $9.40M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $4.84M derived: sum of 2 quarters · filed 2026-03-31 | $7.79M derived: sum of 3 quarters · filed 2026-03-31 | $11.15M 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | $2.71M 10-Q · filed 2025-11-13 | $5.67M derived: sum of 2 quarters · filed 2025-11-13 | $9.02M 10-Q · filed 2025-11-13 | $12.91M derived: sum of 4 quarters · filed 2026-03-31 | ||||
| 2024-06-30 | $2.95M 10-Q · filed 2025-08-13 | $6.31M 10-Q · filed 2025-08-13 | $10.20M derived: sum of 3 quarters · filed 2026-03-31 | $14.74M derived: sum of 4 quarters · filed 2026-03-31 | ||||
| 2024-03-31 | $3.35M 10-Q · filed 2025-05-14 | $7.25M derived: sum of 2 quarters · filed 2026-03-31 | $11.79M derived: sum of 3 quarters · filed 2026-03-31 | $16.47M derived: sum of 4 quarters · filed 2026-03-31 | ||||
| 2023-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $8.43M derived: sum of 2 quarters · filed 2026-03-31 | $13.12M derived: sum of 3 quarters · filed 2026-03-31 | $16.73M 10-K · filed 2026-03-31 | ||||
| 2023-09-30 | $4.54M 10-Q · filed 2024-11-14 | $9.22M derived: sum of 2 quarters · filed 2024-11-14 | $12.84M 10-Q · filed 2024-11-14 | $15.85M derived: sum of 4 quarters · filed 2025-03-27 | ||||
| 2023-06-30 | $4.68M 10-Q · filed 2024-08-14 | $8.30M 10-Q · filed 2024-08-14 | $11.32M derived: sum of 3 quarters · filed 2025-03-27 | $13.80M derived: sum of 4 quarters · filed 2025-03-27 | ||||
| 2023-03-31 | $3.62M 10-Q · filed 2024-05-15 | $6.63M derived: sum of 2 quarters · filed 2025-03-27 | $9.12M derived: sum of 3 quarters · filed 2025-03-27 | $10.61M derived: sum of 4 quarters · filed 2025-03-27 | ||||
| 2022-12-31 | $3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $5.50M derived: sum of 2 quarters · filed 2025-03-27 | $7.00M derived: sum of 3 quarters · filed 2025-03-27 | $7.07M 10-K · filed 2025-03-27 | ||||
| 2022-09-30 | $2.48M 10-Q · filed 2023-11-14 | $2.03M 10-Q · filed 2022-11-09 | $3.98M derived: sum of 2 quarters · filed 2023-11-14 | $4.05M 10-Q · filed 2023-11-14 | $3.24M 10-Q · filed 2022-11-09 | $4.08M derived: sum of 4 quarters · filed 2024-03-28 | ||
| 2022-06-30 | $1.49M 10-Q · filed 2023-08-14 | $1.14M 10-Q · filed 2022-08-09 | $1.57M 10-Q · filed 2023-08-14 | $1.21M 10-Q · filed 2022-08-09 | $1.60M derived: sum of 3 quarters · filed 2024-03-28 | $1.64M derived: sum of 4 quarters · filed 2024-03-28 | ||
| 2022-03-31 | $76.00K 10-Q · filed 2023-05-15 | $104.00K derived: sum of 2 quarters · filed 2024-03-28 | $144.00K derived: sum of 3 quarters · filed 2024-03-28 | $225.00K derived: sum of 4 quarters · filed 2024-03-28 | ||||
| 2021-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $68.00K derived: sum of 2 quarters · filed 2024-03-28 | $149.00K derived: sum of 3 quarters · filed 2024-03-28 | $298.00K 10-K · filed 2024-03-28 | ||||
| 2021-09-30 | $40.00K 10-Q · filed 2022-11-09 | $121.00K derived: sum of 2 quarters · filed 2022-11-09 | $270.00K 10-Q · filed 2022-11-09 | $685.00K derived: sum of 4 quarters · filed 2023-03-28 | ||||
| 2021-06-30 | $81.00K 10-Q · filed 2022-08-09 | $230.00K 10-Q · filed 2022-08-09 | $645.00K derived: sum of 3 quarters · filed 2023-03-28 | $1.29M derived: sum of 4 quarters · filed 2023-03-28 | ||||
| 2021-03-31 | $149.00K 10-Q · filed 2022-05-10 | $564.00K derived: sum of 2 quarters · filed 2023-03-28 | $1.21M derived: sum of 3 quarters · filed 2023-03-28 | $1.91M derived: sum of 4 quarters · filed 2023-03-28 | ||||
| 2020-12-31 | $415.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $1.06M derived: sum of 2 quarters · filed 2023-03-28 | $1.76M derived: sum of 3 quarters · filed 2023-03-28 | $2.97M 10-K · filed 2023-03-28 | $2.90M 10-K · filed 2021-03-01 | |||
| 2020-09-30 | $645.00K 10-Q · filed 2021-11-09 | $1.34M derived: sum of 2 quarters · filed 2021-11-09 | $2.55M 10-Q · filed 2021-11-09 | $3.05M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $698.00K 10-Q · filed 2021-08-09 | $1.91M 10-Q · filed 2021-08-09 | $2.40M derived: sum of 3 quarters · filed 2022-03-01 | $2.68M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $1.21M 10-Q · filed 2021-05-10 | $1.71M derived: sum of 2 quarters · filed 2022-03-01 | $1.98M derived: sum of 3 quarters · filed 2022-03-01 | $2.31M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $498.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $775.00K derived: sum of 2 quarters · filed 2022-03-01 | $1.11M derived: sum of 3 quarters · filed 2022-03-01 | $1.57M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $277.00K 10-Q · filed 2020-11-09 | $354.00K 10-Q · filed 2019-11-12 | $608.00K derived: sum of 2 quarters · filed 2020-11-09 | $1.07M 10-Q · filed 2020-11-09 | $1.26M 10-Q · filed 2019-11-12 | $1.69M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-30 | $331.00K 10-Q · filed 2020-08-10 | $431.00K 10-Q · filed 2019-08-14 | $793.00K 10-Q · filed 2020-08-10 | $911.00K 10-Q · filed 2019-08-14 | $1.41M derived: sum of 3 quarters · filed 2021-03-01 | $1.41M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-31 | $462.00K 10-Q · filed 2020-05-11 | $480.00K 10-Q · filed 2019-05-15 | $1.08M derived: sum of 2 quarters · filed 2021-03-01 | $1.08M derived: sum of 3 quarters · filed 2021-03-01 | $1.16M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2018-12-31 | $617.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $617.00K derived: sum of 2 quarters · filed 2021-03-01 | $693.00K derived: sum of 3 quarters · filed 2021-03-01 | $617.00K 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 | $76.00K derived: sum of 2 quarters · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | |||||
| 2018-06-30 | $76.00K 10-Q · filed 2019-08-14 | $124.00K 10-Q · filed 2019-08-14 | ||||||
| 2018-03-31 | $48.00K 10-Q · filed 2019-05-15 | |||||||
| 2017-12-31 | $29.00K 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |